Theravance Inc (NASDAQ:THRX)

16.75
Delayed Data
As of Apr 20
 -0.38 / -2.22%
Today’s Change
10.58
Today|||52-Week Range
31.80
+18.37%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Glaxosmithkline Plc
Buy5/09/2014317,770$26.86$8.5M-37.64%
Glaxosmithkline Plc
Buy8/11/2014172,651$22.13$3.8M-24.31%
Glaxosmithkline Plc
Buy3/02/201592,674$19.22$1.8M-12.85%
Winningham Rick E
Chief Executive Officer
Sale5/09/201450,225$26.86$1.3M-37.64%
Lee Junning
Senior Vice President-Technical Operations
Sale8/13/201453,424$22.50$1.2M-25.98%
Mammen Mathai
Senior VP-Research & Early Clinical Development
Sale5/09/201422,833$26.86$613.3K-37.64%
Shafer Bradford J
General Counsel & Senior Vice President
Sale5/09/201422,833$26.86$613.3K-37.64%
Shafer Bradford J
General Counsel & Senior Vice President
Sale8/11/201427,108$22.12$599.6K-24.31%
Aguiar Michael W
Chief Financial Officer & Senior Vice President
Sale5/09/201421,405$26.86$574.9K-37.64%
Blum Leonard M
Chief Communications Officer & Senior VP
Sale5/09/201418,849$26.86$506.3K-37.64%
Page of 8

To view my watchlist

Not a member yet?

Sign up now for a free account